Stephen Maxted Ansell, MD, PhD

  • 23318 Citations
  • 81 Scopus h-Index
1989 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Letter
2020

Predictors of short-term survival in Waldenström Macroglobulinemia

Ruan, G., Zanwar, S., Abeykoon, J. P., Ansell, S. M., Gertz, M., Go, R. S., Muchtar, E., Gonsalves, W., Paludo, J., Thanarajasingam, G., Inwards, D. J., Thompson, C. A., Habermann, T. M., Lin, Y., Nowakowski, G. S., Bisneto, J. C. V., Dispenzieri, A., Lacy, M. Q., Buadi, F. K., Dingli, D. & 5 others, Kourelis, T., Warsame, R., Rajkumar, S. V., Kumar, S. K. & Kapoor, P., 2020, In : Leukemia and Lymphoma. p. 1-5 5 p.

Research output: Contribution to journalLetter

Three-year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphoma

LaCasce, A. S., Bociek, R. G., Sawas, A., Caimi, P., Agura, E., Matous, J., Ansell, S. M., Crosswell, H. E., Islas-Ohlmayer, M., Behler, C., Cheung, E., Forero-Torres, A., Vose, J., O’Connor, O. A., Josephson, N., Wang, Y. & Advani, R., Jan 1 2020, (Accepted/In press) In : British journal of haematology.

Research output: Contribution to journalLetter

Open Access
1 Scopus citations
2019

Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas

Ellin, F., Maurer, M. J., Srour, L., Farooq, U., Jerkeman, M., Connors, J. M., Smedby, K. E., Bennani, N. N., Ansell, S. M., Slack, G. W., Cerhan, J. R., Relander, T., Feldman, A. L. & Savage, K. J., Aug 2019, In : British journal of haematology. 186, 3, p. e24-e27

Research output: Contribution to journalLetter

Open Access
2018

A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts

Ghesquières, H., Larrabee, B. R., Casasnovas, O., Maurer, M. J., McKay, J. D., Ansell, S. M., Montgomery, D., Asmann, Y. W., Farrell, K., Verney, A., Slager, S. L., Allmer, C., Perrot, A., Delarue, R., Habermann, T. M., Dupuis, J., Link, B. K., Canioni, D., Dogan, A., Cozen, W. & 3 others, Jarrett, R. F., Cerhan, J. R. & Salles, G., Jan 2018, In : British journal of haematology. 180, 2, p. 286-290 5 p.

Research output: Contribution to journalLetter

6 Scopus citations
3 Scopus citations

In reply

Kapoor, P., Gertz, M. & Ansell, S. M., May 1 2018, In : JAMA oncology. 4, 5, p. 745-746 2 p.

Research output: Contribution to journalLetter

Reply to Castillo et al.

Abeykoon, J. P., King, R., Ansell, S. M., Rajkumar, S. V., Paludo, J., Kyle, R. A., Kumar, S. K., Gertz, M. & Kapoor, P., Mar 1 2018, In : American Journal of Hematology. 93, 3, p. E71-E73

Research output: Contribution to journalLetter

2 Scopus citations
2017

First report of MYD88L265P somatic mutation in IgM-associated light chain amyloidosis

Chakraborty, R., Novak, A. J., Ansell, S. M., Muchtar, E., Kapoor, P., Hayman, S. R., Dispenzieri, A., Buadi, F. K., Lacy, M., King, R. & Gertz, M., Mar 16 2017, In : Amyloid. 24, p. 42-43 2 p.

Research output: Contribution to journalLetter

1 Scopus citations

Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma

Connors, J. M., Ansell, S. M., Fanale, M., Park, S. I. & Younes, A., Sep 14 2017, In : Blood. 130, 11, p. 1375-1377 3 p.

Research output: Contribution to journalLetter

22 Scopus citations

Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: A replication study and combined analysis of 508 patients

Rossille, D., Azzaoui, I., Feldman, A. L., Maurer, M. J., Labouré, G., Parrens, M., Pangault, C., Habermann, T. M., Ansell, S. M., Link, B. K., Tarte, K., Witzig, T. E., Lamy, T., Slager, S. L., Roussel, M., Milpied, N., Cerhan, J. R. & Fest, T., Apr 1 2017, In : Leukemia. 31, 4, p. 988-991 4 p.

Research output: Contribution to journalLetter

22 Scopus citations
6 Scopus citations
2016

First report of MYD88L265P somatic mutation in IgM-associated light-chain amyloidosis

Chakraborty, R., Novak, A. J., Ansell, S. M., Muchtar, E., Kapoor, P., Hayman, S. R., Dispenzieri, A., Buadi, F. K., Lacy, M. Q., King, R. L. & Gertz, M. A., Jun 9 2016, In : Blood. 127, 23, p. 2936-2938 3 p.

Research output: Contribution to journalLetter

11 Scopus citations
2013

FCGR2A and FCGR3A polymorphisms in classical hodgkin lymphoma by epstein-barr virus status

Ghesquières, H., Dogan, A., Link, B. K., Maurer, M. J., Cunningham, J. M., Novak, A. J., Larrabee, B. R., Slager, S. L., Allmer, C., Habermann, T. M., Ansell, S. M. & Cerhan, J. R., Oct 21 2013, In : Leukemia and Lymphoma. 54, 11, p. 2571-2573 3 p.

Research output: Contribution to journalLetter

6 Scopus citations
2012

Beyond targeting malignant B cells

Ansell, S. M., Jul 1 2012, In : The Lancet Oncology. 13, 7, p. 657-658 2 p.

Research output: Contribution to journalLetter

2011

Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and Sézary syndrome

Wada, D. A., Wilcox, R. A., Harrington, S. M., Kwon, E. D., Ansell, S. M. & Comfere, N. I., Mar 1 2011, In : American journal of hematology. 86, 3, p. 325-327 3 p.

Research output: Contribution to journalLetter

37 Scopus citations

The definition of IgM multiple myeloma

Schuster, S. R., Rajkumar, S. V., Dispenzieri, A., Morice, W., Aspitia, A. M., Ansell, S., Kyle, R. & Mikhael, J., Aug 1 2011, In : American journal of hematology. 86, 8, p. 718-719 2 p.

Research output: Contribution to journalLetter

1 Scopus citations
2010

Author reply: Flows and flaws in primary CNS lymphoma

Ansell, S. M. & Rajkumar, S. V., Aug 1 2010, In : Nature Reviews Clinical Oncology. 7, 8

Research output: Contribution to journalLetter

Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines

Wilcox, R. A., Sun, D. X., Novak, A., Dogan, A., Ansell, S. M. & Feldman, A. L., Jan 2010, In : Leukemia. 24, 1, p. 229-232 4 p.

Research output: Contribution to journalLetter

41 Scopus citations
2007
18 Scopus citations
2002

Terminal plasmocytoid differentiation of malignant B cells induced by autotumor-reactive CD4+ T cells in one case of splenic marginal zone B-cell lymphoma [2]

Ansell, S. M., Witzig, T. E., Kurtin, P. J., Sloan, J. A., Jelinek, D. F., Howell, K. G., Markovic, S. N., Habermann, T. M., Klee, G. G., Atherton, P. J. & Erlichman, C., Jan 1 2002, In : Blood. 99, 1, p. 388-390 3 p.

Research output: Contribution to journalLetter

2 Scopus citations

T helper cell activation in B-cell lymphomas [1] (multiple letters)

Bosshart, H., Ansell, S. M., Jelinek, D. F., Wettstein, P. J. & Witzig, T. E., Jun 15 2002, In : Journal of Clinical Oncology. 20, 12, p. 2904-2905 2 p.

Research output: Contribution to journalLetter

2 Scopus citations
1993

A phase II trial of a chemotherapy combination in elderly patients with aggressive lymphoma

Ansell, S. M. & Falkson, G., Feb 1993, In : Annals of Oncology. 4, 2, 1 p.

Research output: Contribution to journalLetter

Open Access
16 Scopus citations